MCID: MYC005
MIFTS: 35

Myocardial Stunning malady

Cardiovascular diseases category

Aliases & Classifications for Myocardial Stunning

About this section
Sources:
10Disease Ontology, 47Novoseek, 12DISEASES, 65UMLS, 36MeSH
See all sources

Aliases & Descriptions for Myocardial Stunning:

Name: Myocardial Stunning 10 47 12 65 36


Classifications:



External Ids:

Disease Ontology10 DOID:9767
MeSH36 D017682

Summaries for Myocardial Stunning

About this section
Wikipedia:68 In cardiology, stunned myocardium is a state when some section of the myocardium (corresponding to area... more...

MalaCards based summary: Myocardial Stunning is related to ischemic bone disease and myocardial infarction. An important gene associated with Myocardial Stunning is SLC9A1 (Solute Carrier Family 9, Subfamily A (NHE1, Cation Proton Antiporter 1), Member 1), and among its related pathways are Endothelins and Detoxification of Reactive Oxygen Species. Affiliated tissues include heart, neutrophil and endothelial, and related mouse phenotypes are muscle and cardiovascular system.

Related Diseases for Myocardial Stunning

About this section

Diseases related to Myocardial Stunning via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 63)
idRelated DiseaseScoreTop Affiliating Genes
1ischemic bone disease30.2EDN1, SLC9A1, SOD1
2myocardial infarction30.1AGTR2, EDN1, SERPINC1, TNNI3, TNNT2
3ischemia10.8
4cardiomyopathy10.7
5coronary artery disease10.5
6acute myocardial infarction10.5
7endotheliitis10.5
8artery disease10.5
9hypertrophic cardiomyopathy10.4
10pulmonary edema10.3
11cardiac arrest10.3
12kidney disease10.3
13aneurysm10.3
14hypoxia10.3
15cardiogenic shock10.3
16ossifying fibroma10.2SERPINC1, SOD1
17coronary heart disease 210.2
18coronary heart disease 510.2
19myocardial infarction 210.2
20coronary heart disease 310.2
21bone mineral density, low10.2
22peripheral vascular disease10.2
23pulmonary hypertension10.2
24chronic kidney failure10.2
25chronic myocardial ischemia10.2
26congestive heart failure10.2
27end stage renal failure10.2
28ischemic heart disease10.2
29primary hyperoxaluria10.2
30cerebritis10.2
31bone development disease10.2
32cervicitis10.2
33congenital heart disease10.2
34coronary stenosis10.2
35hyperthyroidism10.2
36impaired renal function disease10.2
37nutritional deficiency disease10.2
38peritonitis10.2
39urinary system disease10.2
40spontaneous coronary artery dissection10.2
41stress cardiomyopathy10.2
42vascular malformation10.2
43complication in hemodialysis10.2
44ataxia10.1KCNJ5, SOD1
45congenital chloride diarrhea10.1EDN1, SERPINC1
46breast angiosarcoma10.1EDN1, SERPINC1
47thyroid angiosarcoma10.1SERPINC1, TNNT2
48hepatoblastoma10.1EDN1, SERPINC1
49nodular malignant melanoma10.0EDN1, SERPINC1
50islet cell tumor10.0EDN1, SERPINC1

Graphical network of the top 20 diseases related to Myocardial Stunning:



Diseases related to myocardial stunning

Symptoms for Myocardial Stunning

About this section

Drugs & Therapeutics for Myocardial Stunning

About this section

Drugs for Myocardial Stunning (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 13)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
HydroxocobalaminapprovedPhase 421713422-51-011953898, 5460373, 44475014
Synonyms:
13422-51-0
22465-48-1
78091-12-0
8017-22-9
Acti-B12
AlphaRedisol
AlphaRedisol (TN)
Axion
Axlon
Benzimidazolyl ribofuranosyl phosphate deriv.
C08230
C62H85CoN13O15P
CHEBI:27786
CHEMBL1200742
CHEMBL235822
CID11622291
CID11953898
CID5460373
CID6433575
CID6474319
Ciplamin H
Coalpha-[alpha-(5,6-dimethylbenzimidazolyl)]-Cobeta-hydroxocobamide
Cobalex
Cobalin H
Cobinamide dihydroxide dihydrogen phosphate (ester), mono(inner salt), 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosylbenzimidazole
Cobinamide hydroxide phosphate 3'-ester with 5,6-dimethyl-1-a-D-ribofuranosylbenzimidazole inner salt
Cobinamide hydroxide phosphate 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosylbenzimidazole inner salt
Cobinamide hydroxide phosphate 3'-ester with 5,6-dimethyl-1-alpha-delta-ribofuranosylbenzimidazole inner salt
Cobinamide, Co-hydroxy-, dihydrogen phosphate (ester), inner salt, 3'-ester with (5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole-kappaN3)
Cobinamide, Co-hydroxy-, f-(dihydrogen phosphate), inner salt, 3'-ester with (5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole-kappaN3)
Cobinamide, dihydroxide, dihydrogen phosphate (ester), mono (inner salt), 3'- ester with 5,6-dimethyl-1-alpha-D-ribofuranosylbenzimidazole
Cobinamide, dihydroxide, dihydrogen phosphate (ester), mono(inner salt), 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole
Cobinamide, hydroxide, dihydrogen phosphate (ester), inner salt, 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole
Codroxomin
Cyanokit
Cyanokit (TN)
D01027
DB00200
Depogamma
Docclan
Docelan
Docelvita
Docevita
Droxomin
Ducobee Hy
Ducobee-Hy
Duradoce
Duralta-12
EINECS 236-533-2
HSDB 3342
HYDROXOCOBALAMIN
Hidroxocobalamina
Hidroxocobalamina [INN-Spanish]
 
Hydro Cobex
Hydrobamine
Hydrocobalamin
Hydrogrisevit
Hydrovit
Hydroxocobalamin
Hydroxocobalamin (JAN/USP/INN)
Hydroxocobalamin Vitamin B12
Hydroxocobalamin [USAN:INN:BAN:JAN]
Hydroxocobalamin acetate
Hydroxocobalamin monohydrochloride
Hydroxocobalamin(alkaline soln.), OH- replaces CN- in Cyanocobalamin)
Hydroxocobalaminacetat
Hydroxocobalamine
Hydroxocobalamine [INN-French]
Hydroxocobalaminum
Hydroxocobalaminum [INN-Latin]
Hydroxocobemine
Hydroxomin
Hydroxy Cobal
Hydroxy vitamin B12
Hydroxycob(lll)alamin
Hydroxycobalamin
Hydroxycobalamine
Hyxobamine
Idrogrisevit
Idrossocobalamina
Idrossocobalamina [DCIT]
LS-54607
Lyovit-H
Neo-Betalin 12
Neo-cytamen
Neo-macrabin
Neo-rojamin
OH-Cbl
OH-Duphar
Ohb12
Oxobemin
Oxolamine (arcum)
Primabalt RP
Redisol-H
S1668_Selleck
Sytobex-H
UNII-Q40X8H422O
Vibeden
Vitadurin
Vitamin B(sub 12a)
Vitamin B-12b
Vitamin B12a
Vitamin B12b
a-(5,6-Dimethylbenzimidazolyl)hydroxocobamide
alpha Cobione
alpha-(5,6-Dimethylbenzimidazolyl)hydroxocobamide
vitamin B-12b
2
Cyanocobalaminapproved, nutraceuticalPhase 421768-19-944176380, 44176380, 5462245
Synonyms:
Anacobin
Bedoz
Berocca PN
Berubigen
Betalin 12
Betalin 12 Crystalline
Betaline-12
Betolvex
Bevidox
Bevidox concentrate
Biocobalamine
Byladoce
Cabadon m
Cernevit-12
Cobadoce forte
Cobalin
Cobavite
Cobex
Cobolin-M
Copharvit 5000
Covit
Crystamin
Crystamine
Crysti-12
Crystimin
Crystwel
Cyano-B12
Cyanobalamin concentrate
Cyanocob(III)alamin
Cyanocobalamin
Cyanocobalamin (JP15/USP)
Cyanocobalamin Co 57 Schilling Test Kit
Cyanocobalamine
Cyanocobalmin
Cyanoject
Cycobemin
Cycolamin
Cykobemin
Cykobeminet
Cyomin
Cyredin
Cytacon
Cytamen
Cytobion
Depinar
Dicopac
Dicopac Kit
Dimethylbenzimidazoylcobamide
Distivit
Docemine
Docibin
Docivit
Dodecabee
Dodecavite
Dodex
Duodecibin
Embiol
Emociclina
Eritrone
 
Erycytol
Erythrotin
Euhaemon
Extrinsic factor
Factor II
Fermin
Fresmin
Hemomin
Hepagon
Hepavis
Hepcovite
Hylugel plus
Infuvite Pediatric
Lactobacillus lactis dorner factor
M.V.I. Pediatric
Macrabin
Megabion
Megalovel
Milbedoce
Millevit
Nagravon
Nascobal
Nascobal (TN)
Neuroforte-R
Normocytin
Novidroxin
Pernaemon
Pernaevit
Pernipuron
Plecyamin
Poyamin
Primabalt
Rebramin
Redamina
Redisol
Rhodacryst
Rubesol
Rubivite
Rubramin
Rubramin PC
Rubratope-57 Kit
Rubratope-60 Kit
Rubripca
Rubrocitol
Ruvite
Shovite
Sytobex
Vi-Twel
Vibal
Vibalt
Vibisone
Virubra
Vita-rubra
Vitabee 12
Vitamin B12
Vitamin B12 Preparation
Vitamin B12 complex
Vitaped
Vitarubin
Vitral
vitamine b12
3
Folic Acidapproved, nutraceuticalPhase 4285159-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic Acid
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
 
Folsaeure
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
4SimendanPhase 4, Phase 250
5Vitamin B 12Phase 4224
6Vitamin B ComplexPhase 42775
7Vitamin B9NutraceuticalPhase 42851
8
CobalaminNutraceuticalPhase 421713408-78-16438156
Synonyms:
5,6-Dimethyl-1-a-D-ribofuranosyl-1H-benzimidazole
5,6-Dimethyl-1-a-D-ribofuranosylbenzimidazole
5,6-Dimethyl-1-alpha-delta-ribofuranosyl-1H-benzimidazole
5,6-Dimethyl-1-alpha-delta-ribofuranosylbenzimidazole
Cob(III)alamin
Cobalamin (III)
Cobalamine
 
Cobinamide ion(1+) dihydrogen phosphate (ester) inner salt 3'-ester
Cobinamide ion(1+) dihydrogen phosphate (ester) inner salt 3'-ester with 5,6-dimethyl-1-alpha-delta-ribofuranosyl-1H-benzimidazole
Hydroxomin
Rubivite
Rubratope-57
Rubratope-60
Ruvite
Vitamin B12
9Vitamin B12NutraceuticalPhase 4217
10FolateNutraceuticalPhase 42851
11
MethylcobalaminNutraceuticalPhase 421713422-55-4
Synonyms:
Algobaz
Co-Methylcobalamin
Hitocobamin M
MeCbl
Mecobalamin
Methycobal
 
Methyl cobalamine
Methyl vitamin B12
Methyl-5,6-dimethylbenzimidazolylcobalamin
Methyl-B12
Methylcob(III)alamin
Methylcobalamin
Methylcobaz
12
Dobutamineapproved9934368-04-236811
Synonyms:
(+-)-4-(2-((3-(P-Hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol
(+-)-4-(2-((3-(p-Hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol
3,4-Dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-beta-phenylethylamine
3,4-dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-beta-phenylethylamine
34368-04-2
34368-04-2 (Parent)
4-(2-{[3-(4-hydroxyphenyl)-1-methylpropyl]amino}ethyl)benzene-1,2-diol
4-(2-{[4-(4-hydroxyphenyl)butan-2-yl]amino}ethyl)benzene-1,2-diol
4-[2-[4-(4-hydroxyphenyl)butan-2-ylamino]ethyl]benzene-1,2-diol
4-{2-[3-(4-hydroxy-phenyl)-1-methyl-propylamino]-ethyl}-benzene-1,2-diol
52663-81-7 (hydrochloride)
74753-15-4
74753-15-4 (hydrobromide)
AC1L1WFF
AC1Q7AD1
BPBio1_000489
BRD-A78322124-003-03-3
BSPBio_000443
C06967
CHEBI:4670
CHEMBL926
CID36811
D03879
DB00841
DL-Dobutamine
DL-dobutamine
Dobutamin
Dobutamina
Dobutamina [INN-Spanish]
Dobutamine
Dobutamine (USP/INN)
Dobutamine Hcl
Dobutamine Hcl in Dextrose 5%
Dobutamine Hydrochloride
 
Dobutamine Tartrate (1:1), (S-(R*,R*))-Isomer
Dobutamine [USAN:BAN:INN]
Dobutamine [USAN]
Dobutamine [Usan:Ban:Inn]
Dobutamine [Usan]
Dobutamine hydrobromide
Dobutamine hydrochloride
Dobutaminum
Dobutaminum [INN-Latin]
Dobutrex
EINECS 277-982-4
HMS2089K05
Inotrex
L001157
LS-174467
LY 81929
Lilly 81929
Lopac0_000365
NCGC00015321-05
NCGC00024629-02
NCGC00024629-03
Prestwick0_000352
Prestwick1_000352
Prestwick2_000352
Prestwick3_000352
Racemic-Dobutamine
Racemic-dobutamine
SPBio_002364
UNII-0WR771DJXV
UNII-3S12J47372
dobutamine
dobutamine(usp)
rac-Dobutamine
rac-dobutamine
racemic-Dobutamine
13Calcium, Dietary3529

Interventional clinical trials:

(show all 14)
idNameStatusNCT IDPhase
1Intracoronary Administration of Levosimendan in Cardiac Surgery PatientsRecruitingNCT01500785Phase 4
2Ranolazine a Potential New Therapeutic ApplicationNot yet recruitingNCT02687269Phase 4
3Adjunctive Mild Hypothermia Therapy to Primary Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction Complicated With Shock: A Feasibility StudyActive, not recruitingNCT00846222Phase 3
4Levosimendan Administration in Neonates With Transposition of the Great ArteriesCompletedNCT01120106Phase 2
5Evaluation of Myocardial Viability by Means of Low-dose Dobutamine Gated SPECT (the DOGS Study)CompletedNCT00213746
6Exercise-induced Changes in Cardiac Function & MorphologyCompletedNCT01179802
7Analysis of Heart Muscle Function Following Exercise in Patients With Heart DiseaseCompletedNCT00001528
8Cardiac Sympathetic Activity in Patients With the Apical Ballooning SyndromeCompletedNCT00586183
9Myocardial Stunning During Hemodialysis: Role of Dialyste Calcium ConcentrationRecruitingNCT02545426
10Trial of Dialysate Sodium in Chronic Hospitalized Hemodialysis PatientsRecruitingNCT02145260
11Serial Echocardiography After Subarachnoid HemorrhageActive, not recruitingNCT00123695
12Risk Assessment by Cardiovascular Biomarkers in Chronic Dialysis PatientsNot yet recruitingNCT02207153
13Steroid-induced Reduction of Surgical Stress StudyWithdrawnNCT00807521
14Characterization of Sympathetic Nerve Activity in Stress CardiomyopathyWithdrawnNCT01048125

Search NIH Clinical Center for Myocardial Stunning


Cochrane evidence based reviews: Myocardial Stunning

Genetic Tests for Myocardial Stunning

About this section

Anatomical Context for Myocardial Stunning

About this section

MalaCards organs/tissues related to Myocardial Stunning:

33
Heart, Neutrophil, Endothelial, Testes, Kidney, Colon, Brain

Animal Models for Myocardial Stunning or affiliated genes

About this section

MGI Mouse Phenotypes related to Myocardial Stunning:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053698.6AGTR2, EDN1, SOD1, TNNI3, TNNT2
2MP:00053857.4AGTR2, EDN1, KCNJ5, SERPINC1, SLC9A1, SOD1
3MP:00053767.2AGTR2, EDN1, OPRD1, SERPINC1, SLC9A1, SOD1
4MP:00107686.5AGTR2, AHSP, EDN1, SERPINC1, SLC9A1, SOD1

Publications for Myocardial Stunning

About this section

Articles related to Myocardial Stunning:

(show top 50)    (show all 413)
idTitleAuthorsYear
1
Prevention of myocardial stunning during percutaneous coronary interventions: novel insights from pre-treatment with glucagon-like peptide-1. (25700753)
2015
2
Hemodialysis-Induced Myocardial Stunning: A Review. (26290919)
2015
3
Seizure-Induced Myocardial Stunning: A Possible Cardiac Link to Sudden Unexpected Death In Epilepsy (SUDEP). (25305671)
2014
4
CMR imaging for the evaluation of myocardial stunning after acute myocardial infarction: a meta-analysis of prospective trials. (23575990)
2013
5
Milrinone and levosimendan administered after reperfusion improve myocardial stunning in swine. (22994851)
2013
6
High-dose erythropoietin during cardiac resuscitation lessens postresuscitation myocardial stunning in swine. (23806450)
2013
7
Non-invasive ventilation for severe TRALI and myocardial stunning: report and literature review. (22869453)
2012
8
Nitric oxide has no obligatory role in isoflurane late preconditioning against myocardial stunning. (23044225)
2012
9
Complex I syndrome in myocardial stunning and the effect of adenosine. (21723387)
2011
10
Postischemic infusion of sivelestat sodium hydrate, a selective neutrophil elastase inhibitor, protects against myocardial stunning in swine. (20464430)
2010
11
Myocardial stunning after electroconvulsive therapy in patients with an apparently normal heart. (19225404)
2009
12
Myocardial stunning following no flow ischaemia is diminished by levosimendan or cariporide, without benefits of combined administration. (17719165)
2008
13
Ca2+ sensitizer superior to catecholamine during myocardial stunning? (18539040)
2008
14
Re: Stress (Takotsubo) cardiomyopathy--a novel pathophysiological hypothesis to explain catecholamine-induced acute myocardial stunning. (18506208)
2008
15
Myocardial stunning due to sudden emotional stress. (15877319)
2005
16
Effects of endogenous adenosine and adenosine receptor agonists on hypoxia-induced myocardial stunning in Guinea-pig atria and papillary muscles. (15076219)
2004
17
Elevated MnSOD is not required for exercise-induced cardioprotection against myocardial stunning. (15031126)
2004
18
Ischemic shortening of action potential duration as a result of KATP channel opening attenuates myocardial stunning by reducing calcium influx. (12190121)
2002
19
Increases in myocardial cyclic GMP attenuate contractile delay in myocardial stunning. (12269791)
2002
20
Clinical manifestations of myocardial stunning. (11491200)
2001
21
Myocardial stunning in exercise-induced ischemia in dogs: lack of late preconditioning. (11123245)
2001
22
Nitric oxide donors attenuate myocardial stunning in conscious rabbits. (10600874)
1999
23
In search of the proteins that cause myocardial stunning. (10473676)
1999
24
Preservation of myofilament calcium responsiveness underlies protection against myocardial stunning by ischemic preconditioning. (10533603)
1999
25
Gated single-photon emission tomography imaging protocol to evaluate myocardial stunning after exercise. (10638404)
1999
26
Nitroglycerin induces late preconditioning against myocardial stunning via a PKC-dependent pathway. (10600873)
1999
27
Effects of azelnidipine, a dihydropyridine calcium antagonist, on myocardial stunning in dogs. (9623715)
1998
28
17-Beta estradiol regulation of myocardial glutathione and its role in protection against myocardial stunning in dogs. (9733360)
1998
29
Functional and ultrastructural evidence of myocardial stunning after acute carbon monoxide poisoning. (9559621)
1998
30
Adenosine attenuates in vivo myocardial stunning with minimal effects on cardiac energetics. (9782373)
1998
31
Myocardial stunning--ups and downs in the Dolomites. (9689434)
1998
32
Nitric oxide donors induce late preconditioning against myocardial stunning and infarction in conscious rabbits via an antioxidant-sensitive mechanism. (9670920)
1998
33
Prospective identification of myocardial stunning using technetium-99m sestamibi-based measurements of infarct size. (9385887)
1997
34
Activation of adenosine receptors before ischemia enhances tolerance against myocardial stunning in the rabbit heart. (8522700)
1996
35
Do ATP-sensitive potassium channels play a role in myocardial stunning? (8534242)
1995
36
The effects of modulation of the L-arginine-nitric oxide pathway on myocardial stunning following repetitive coronary occlusion in dogs. (8857235)
1995
37
Commentary on myocardial stunning and its clinical relevance. (8534253)
1995
38
Myocardial stunning following respiratory arrest. (7587461)
1995
39
Diagnosis of myocardial stunning: a new use for myocardial contrast and dobutamine echocardiography. (8680143)
1995
40
Acute plaque rupture and myocardial stunning in patient with normal coronary arteriography. (7603266)
1995
41
Attenuation of myocardial stunning by the ACE inhibitor ramiprilat through a signal cascade of bradykinin and prostaglandins but not nitric oxide. (8087948)
1994
42
Inhibition of glycolysis or increased perfusate H+ buffering capacity, but not their combination, attenuates myocardial stunning. (8287444)
1993
43
Myocardial stunning and preconditioning: age, species, and model related differences: role of AMP-5'-nucleotidase in myocardial injury and protection. (8461514)
1993
44
Transient left ventricular dyskinesia as a consequence of myocardial stunning. (1442512)
1992
45
Prominent negative T waves with QT prolongation indicate reperfusion injury and myocardial stunning. (1339791)
1992
46
Myocardial stunning following coronary angioplasty: protective effects of calcium-channel blockers. (1282609)
1992
47
Decreased myofilament responsiveness in myocardial stunning follows transient calcium overload during ischemia and reperfusion. (1423931)
1992
48
Effects of an increase in intracellular free [Mg2+] after myocardial stunning on sarcoplasmic reticulum Ca2+ transport. (1884459)
1991
49
Effect of global myocardial stunning on Ca2(+)-sensitive myofibrillar ATPase activity and creatine kinase kinetics. (2144402)
1990
50
Acidosis during early reperfusion prevents myocardial stunning in perfused ferret hearts. (3417873)
1988

Variations for Myocardial Stunning

About this section

Expression for genes affiliated with Myocardial Stunning

About this section
Search GEO for disease gene expression data for Myocardial Stunning.

Pathways for genes affiliated with Myocardial Stunning

About this section

Pathways related to Myocardial Stunning according to GeneCards Suite gene sharing:

idSuper pathways (with members indented)ScoreTop Affiliating Genes
19.7EDN1, SLC9A1
2
Show member pathways
9.6SOD1, SOD3
3
Show member pathways
9.6SOD1, SOD3
49.6SOD1, SOD3
59.6SLC9A1, TNNI3, TNNT2
6
Show member pathways
8.6AGTR2, OPRD1, SLC9A1, TNNI3, TNNT2

GO Terms for genes affiliated with Myocardial Stunning

About this section

Cellular components related to Myocardial Stunning according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1troponin complexGO:000586110.2TNNI3, TNNT2
2sarcomereGO:00300179.9TNNI3, TNNT2
3myofibrilGO:00300169.8TNNI3, TNNT2
4T-tubuleGO:00303159.7KCNJ5, SLC9A1

Biological processes related to Myocardial Stunning according to GeneCards Suite gene sharing:

(show all 22)
idNameGO IDScoreTop Affiliating Genes
1negative regulation of ATPase activityGO:003278010.3TNNI3, TNNT2
2regulation of muscle contractionGO:000693710.3TNNI3, TNNT2
3cellular sodium ion homeostasisGO:000688310.3AGTR2, SLC9A1
4ventricular cardiac muscle tissue morphogenesisGO:005501010.2TNNI3, TNNT2
5response to copper ionGO:004668810.1SOD1, SOD3
6positive regulation of cardiac muscle hypertrophyGO:001061310.1EDN1, SLC9A1
7heart contractionGO:006004710.0SOD1, TNNI3
8regulation of pHGO:000688510.0EDN1, SLC9A1
9response to reactive oxygen speciesGO:000030210.0SOD1, SOD3
10removal of superoxide radicalsGO:001943010.0SOD1, SOD3
11superoxide metabolic processGO:00068019.9SOD1, SOD3
12cardiac muscle contractionGO:00600489.9TNNI3, TNNT2
13regulation of mitochondrial membrane potentialGO:00518819.8OPRD1, SOD1
14positive regulation of nitric oxide biosynthetic processGO:00454299.8AGTR2, EDN1
15positive regulation of renal sodium excretionGO:00358159.8AGTR2, EDN1
16muscle filament slidingGO:00300499.8TNNI3, TNNT2
17superoxide anion generationGO:00425549.6EDN1, SOD1
18regulation of sensory perception of painGO:00519309.4EDN1, OPRD1, SLC9A1
19regulation of blood pressureGO:00082179.4AGTR2, EDN1, SOD1
20response to muscle stretchGO:00359949.4EDN1, SLC9A1
21heart developmentGO:00075079.3EDN1, TNNI3, TNNT2
22cellular response to hypoxiaGO:00714569.1EDN1, OPRD1, SLC9A1

Molecular functions related to Myocardial Stunning according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1protein phosphatase 2B bindingGO:00303469.7SLC9A1, SOD1
2superoxide dismutase activityGO:00047849.6SOD1, SOD3
3troponin C bindingGO:00301729.6TNNI3, TNNT2

Sources for Myocardial Stunning

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet